DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / 858 Therapeutics, Inc.
858 Therapeutics, Inc.
Stage unknownSan Diego, CAPharmaceuticals
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jun 26, 2024Form D equity offering · $25.2M (form d sold) · 12 investorsFact SEC EDGAR Form D data sets (quarterly) · “858 Therapeutics, Inc. filed Form D: $25,175,501 sold of $50,350,497, Pharmaceuticals”
Investors on record
1 edges
- Versant Venture Management, LLC board only, Clare Ozawa (strongly supported) Inference sec.gov
People
3 officers, 4 directors
- James Veal Executive Officer sec.gov
- Katherine Bell-Mcguinn Executive Officer sec.gov
- Stafford Jeffrey Executive Officer/Director sec.gov
- Jane Huang Director Fact
- Monal Mehta Director Fact
- ALI Behbahani Director Fact
- Clare Ozawa Director Inference
Timeline
1
- Jul 11, 2024858 Therapeutics, Inc. filed Form D: $25,175,501 sold of $50,350,497, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $25.2M Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $50.4M Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-06-26 Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 12 Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 3115 Merryfield Row, Suite 110, SAN DIEGO, CA, 92121 Jul 11, 2024 Fact SEC EDGAR Form D data sets (quarterly)